Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015
Summary
GlobalDatas clinical trial report, “Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium Difficile Infections (Clostridium Difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Datas proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Clostridium Difficile Infections (Clostridium Difficile Associated Disease) 30
Sep 28, 2015: Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial 30
Sep 21, 2015: Synthetic Biologics Reports First Analysis Demonstrating SYN-004's Ability to Protect the Microbiome from Damage Caused by IV Antibiotics in a Humanized Pig Model 30
Sep 20, 2015: Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint 31
Sep 18, 2015: Summit Therapeutics Presents New Positive Preclinical Data on Novel C. difficile Antibiotic SMT19969 at ICAAC 2015 32
Sep 10, 2015: Summit Therapeutics Completes Targeted Enrolment for SMT19969 Phase 2 Trial for C. difficile Infection 33
Jul 28, 2015: Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study 33
Jul 21, 2015: MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the treatment of multi-resistant Clostridium Difficile infections 34
Clinical Trial Profile Snapshots 35
Appendix 134
Abbreviations 134
Definitions 134
Research Methodology 135
Secondary Research 135
About GlobalData 136
Contact Us 136
Disclaimer 137
Source 137
List Of Tables
List of Tables
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
List Of Figures
List of Figures
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 135
